Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 17:14:28.
doi: 10.1186/1471-2393-14-28.

Anti-diabetic drug utilization of pregnant diabetic women in us managed care

Caitlin A Knox  1 , Joseph A C Delaney, Almut G Winterstein
Affiliations

Anti-diabetic drug utilization of pregnant diabetic women in us managed care

Caitlin A Knox et al. BMC Pregnancy Childbirth. .

Abstract

Background: With the increasing prevalence of type 2 diabetes in young adulthood, treatment of diabetes in pregnancy faces new challenges. Anti-diabetic drug utilization patterns of pregnant women with pre-existing diabetes are poorly described. We aim to describe anti-diabetic (AD) agent utilization among diabetic pregnant women.

Methods: We utilized IMS LifeLink, including administrative claims data of patients in US managed care plans, to establish a retrospective cohort of women, age 18-46 years (N = 96,740) with billed procedures for a live birth, and a 12 month eligibility period before and 3 month after delivery. Diabetes mellitus was identified from ≥2 in- or outpatient claims with diagnoses (ICD-9-CM 250.XX) before pregnancy. We estimated the prevalence of AD drugs before, during and after pregnancy, and secular trends across the study period (1999-2009), using linear regression. A sensitivity analysis was conducted to identify the extent of misclassification of trimesters.

Results: Almost six percent (n = 5,581) of the live birth cohort had diabetes mellitus. Throughout the study, 48% (1999) and 78% (2009) (p < 0.0001) of diabetic women received AD drugs during pregnancy. The most common AD drugs during pregnancy were insulin, metformin, sulfonylureas, thiazolidinediones (TZD), and combination AD. The annual prevalence of insulin use increased by only 1% from 39% (1999) to 40% (2009) (p = 0.589) during pregnancy, while use of sulfonylureas and metformin increased from 2.5% and 4.2% (1999) to 17.3% and 15.3% (2009) (p < 0.0001), respectively. Insulin and sulfonylurea use steadily increased in prevalence from the 1st to 3rd trimester (16.5% and 3.3% to 33.0% and 7.5%), while metformin and TZD use decreased (11.4% and 1.6% to 3.8% and 0.2%).

Conclusions: AD use during pregnancy demonstrates the need for additional investigation regarding safety and efficacy of AD drugs on maternal outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Annual prevalence of anti-diabetic treatment before, during and after pregnancy.
Figure 2
Figure 2
Annual prevalence of anti-diabetic drug utilization during pregnancy by drug class.
Figure 3
Figure 3
Pooled annual prevalence of anti-diabetic drug utilization, by drug class: before, during, and after pregnancy.
See this image and copyright information in PMC

References

    1. Diagnosed and undiagnosed diabetes in the United States, all ages, 2010. [ http://www.cdc.gov/diabetes/pubs/estimates11.htm#1]
    1. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care. 2006;29(6):1263–1268. doi: 10.2337/dc06-0062. - DOI - PubMed
    1. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care. 1998;21(6):889–895. doi: 10.2337/diacare.21.6.889. - DOI - PubMed
    1. Coustan DR. Pre-conception planning. The relationship's the thing. Diabetes Care. 1998;21(6):887–888. doi: 10.2337/diacare.21.6.887. - DOI - PubMed
    1. Janz NK, Herman WH, Becker MP, Charron-Prochownik D, Shayna VL, Lesnick TG, Jacober SJ, Fachnie JD, Kruger DF, Sanfield JA. Diabetes and pregnancy. Factors associated with seeking pre-conception care. Diabetes Care. 1995;18(2):157–165. doi: 10.2337/diacare.18.2.157. - DOI - PubMed

Publication types